Skip to content

furazolidone; a cheap drug for eradication of helicobacter pylori

Comparison between(clarithromicin- based and furazolidon- based) triple therapy for Helicobacter Pylori treatment

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013112715566N1
Enrollment
120
Registered
2014-04-02
Start date
2014-03-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori induced. Gastric ulcer

Interventions

Intervention 1: Furazolidon 100 mg/Bd +Amoxicillin 1 gr / Bd + Omeprazple 20 mg /Bd for 2 weeks for half number of patients and continued 4-6 weeks by acid suppression agents. Intervention 2: Clarit
Treatment - Drugs
Furazolidon 100 mg/Bd +Amoxicillin 1 gr / Bd + Omeprazple 20 mg /Bd for 2 weeks for half number of patients and continued 4-6 weeks by acid suppression agents
Clarithromycin 500 mg /Bd + Amoxicillin 1 g /Bd + omeprazole 20 mg /Bd for 2 weeks for half number of patients and continued 4-6 weeks by acid suppression agents.

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient with gastric disorders that infection of HP is proved by endoscopy; he /she should not have surgery of GI system in the past, no smoker, no pregnant and haven't had any history of hemolytic anemia . Exclusion criteria: have not any interest for going on treatment, who didn't do consumption of regimen correctly ,who had to used NSAIDs or other antibiotic for else reason .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Urease Breath Test. Timepoint: Before intervention and six weeks after after intervention. Method of measurement: Lab test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Safiabadi

Qazvin University of Medical Sciences

Hamid.safiabadi@ut.ac.ir+98 28 1379 0620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026